MedCom has been founded in 1997 and is an entirely privately-owned company. We offer innovative & advanced imaging-based products with an emphasis on cancer treatment and interventional navigation. All our products are either dedicated to therapy or are motivated by treatment procedures. As an OEM/B2B company MedCom’s products are integrated by many world-wide acting medical companies.
Our aim is to pioneer each and every product we are working with. Due to our extensive exchange with top-members of the research community and some of the world-best physicians, we are permanently exposed to new and upcoming medical needs from the field. As examples, we commercially released 3D ultrasound in 1996, irradiation virtual simulation in 1999, HDR brachytherapy as monotherapy in 2002, fusion imaging in 2003, proton verification in 2004 and transperineal prostate fusion-biopsy in 2007. All these – and several other- technologies have been world-wide commercially pioneered by MedCom and belong today to established standard of high-end medical care.
Over the years MedCom has been awarded by several academic and professional awards documenting the appreciation of the community and the quality of our products. MedCom regularly participates ambitious R&D projects funded by the European Commission, the German Ministry of Research etc. Joining such leading-edge R&D projects is part of our strategy of permanent innovation and technical leadership.
Key persons
Key persons

Georgios Sakas
Founder
Prof. Dr.-Ing.
Georgios Sakas
Is the founder, majority shareholder, and managing director of the company. He received in 1987 a Diploma (MSc) in Computer Engineering and in 1992 a Ph.D. in Computer graphics, both at the TU Darmstadt. Between 1994 and 2012 he has also been heading the “Cognitive Computing & Medical Imaging” department by Fraunhofer IGD.
Since 1998 he associated adjunct professor at NTU Athens and since 2007 honorary professor at the TU Darmstadt. His research includes medical imaging, surgical navigation and treatment planning systems. He supervised 23 PhD and dozens of graduation students’ theses, published/co-edited 10 books & proceedings, co-authored ca. 200 scientific papers, and received over a dozen scientific awards.
He serves as reviewer by the European Commission, is member of the CIP Strategic Advisory Board of the EU, serves in the board of numerous international conferences and scientific magazines and as business plan and/or innovation evaluator for funding organisations and ministries.

Marcus Grimm
co-share-holder
Download Brochures
Simple & Clearly Description of our Featured Projects

